Physician profile
Dana H Waters
NPI 1063513588
$1,843.99
in general payments reported to CMS, 2019-2025
26 companies · $786 in 2025
The $786 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $101 · 2021: $88.07 · 2022: $105 · 2023: $340 · 2024: $162 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $647.83 | 2023-2025 | |
| Smith+Nephew, INC. | $237.08 | 2019-2025 | Collagenase Santyl, Regranex |
| Abbott Laboratories | $165.91 | 2023 | Proclaim |
| Stryker Corporation | $151.98 | 2019-2024 | 7 X 23mm Citrelock Implant, Citrefix, Easyfuse |
| Paratek Pharmaceuticals, INC. | $87.66 | 2023-2025 | Nuzyra |
| Nabriva Therapeutics, Plc | $62.69 | 2020-2021 | |
| Sanara Medtech INC. | $60.05 | 2022-2023 | Celleraterx |
| Convatec INC. | $50.69 | 2023-2024 | |
| Averitas Pharma INC. | $39.77 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $37.70 | 2024-2025 | |
| Nevro Corp. | $31.89 | 2022 | |
| Solventum Corporation | $28.09 | 2025 | Activ.A.C. |
| Abbvie INC. | $23.75 | 2021 | |
| Tactile Systems Technology INC | $23.14 | 2019 | |
| Sandoz INC. | $23.01 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $20.59 | 2025 | Physio-Stim |
| Grt US Holding, INC. | $18.69 | 2022 | |
| Osiris Therapeutics INC. | $18.55 | 2019 | |
| Organogenesis INC. | $18.49 | 2019 | |
| Globus Medical, INC. | $18.46 | 2025 | Senza |
| Novus Surgical Consultants | $15.57 | 2025 | |
| Medtronic, INC. | $15.02 | 2025 | Inceptiv |
| Integra Lifesciences Corporation | $13.67 | 2021 | |
| Kci USA, INC. | $13.30 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $10.66 | 2021 | |
| Paragon 28, INC. | $9.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.